ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY) approved a 1-for-10 share consolidation effective at market open on November 6, 2025. The consolidation will reduce issued and outstanding common shares from 374,114,284 pre-consolidation to approximately 37,411,430 post-consolidation, subject to rounding.
Proportionate adjustments will apply to outstanding stock options, warrants, and other convertibles. New CUSIP 290257500 and ISIN CA2902575000 will apply. Fractional shares will be rounded down if <0.5 and rounded up if ≥0.5. Registered shareholders in certificated form will receive a letter of transmittal from Computershare; DRS holders will receive automatic post-consolidation DRS statements. Non-registered holders should consult their intermediaries. Warrant holders will be notified under the applicable warrant indentures.
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY) ha approvato una consolidazione azionaria 1-for-10 efficace all'apertura del mercato il 6 novembre 2025. La consolidazione ridurrà le azioni ordinarie emesse e in circolazione da 374.114.284 pre-consolidamento a circa 37.411.430 post-consolidazione, soggetta a arrotondamento.
Gli aggiustamenti proporzionali si applicheranno a opzioni azionarie in circolazione, warrant e altri convertibili. Saranno applicati un nuovo CUSIP 290257500 e ISIN CA2902575000. Le frazioni azionarie saranno arrotondate per difetto se <0,5 e per eccesso se ≥0,5. Azionisti registrati in forma certificata riceveranno una lettera di trasmissione da Computershare; i detentori DRS riceveranno automaticamente le dichiarazioni DRS post-consolidamento. I detentori non registrati dovrebbero consultare i loro intermediari. I detentori di warrant saranno notificati secondo le rispettive clausole dei warrant.
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY) aprobó una consolidación de acciones de 1 por 10, vigente a la apertura del mercado el 6 de noviembre de 2025. La consolidación reducirá las acciones comunes emitidas y en circulación de 374,114,284 antes de la consolidación a aproximadamente 37,411,430 después de la consolidación, sujeto a redondeo.
Los ajustes proporcionados se aplicarán a opciones sobre acciones en circulación, warrants y otros convertibles. Se aplicarán un nuevo CUSIP 290257500 y el ISIN CA2902575000. Las fracciones de acciones se redondearán hacia abajo si <0,5 y hacia arriba si ≥0,5. Los accionistas registrados en forma certificada recibirán una carta de transmisión de Computershare; los titulares de DRS recibirán automáticamente las declaraciones post-consolidación de DRS. Los titulares no registrados deben consultar a sus intermediarios. Los tenedores de warrants serán notificados conforme a las cláusulas aplicables de los warrants.
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY)가 2025년 11월 6일의 시장 개장 시점에 1대 10의 주식 합병을 승인했습니다. 합병으로 발행 및 유통 중인 보통주 수가 합병 전 374,114,284에서 합병 후 약 37,411,430로 감소하며, 반올림에 따라 달라질 수 있습니다.
현존 주식옵션, 워런트 및 기타 전환가능증권에 비례 조정이 적용됩니다. 새로운 CUSIP 290257500 및 ISIN CA2902575000이 적용됩니다. 소수 주식은 <0.5일 때 내림, ≥0.5일 때 올림으로 반올림됩니다. 증서 형태로 등록된 주주들은 Computershare로부터 송환 서한을 받게 되며, DRS 보유자는 합병 후 자동으로 DRS 명세서를 받습니다. 비등록 주주는 중개기관에 문의해야 합니다. 워런트 보유자는 해당 워런트의 관련 규정에 따라 통지됩니다.
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY) a approuvé une consolidation d’actions de 1 pour 10, entrée en vigueur à l’ouverture du marché le 6 novembre 2025. La consolidation réduira les actions ordinaires émises et en circulation de 374 114 284 avant consolidation à environ 37 411 430 après consolidation, sous réserve d’arrondi.
Des ajustements proportionnels s’appliqueront aux options d’achat d’actions en circulation, warrants et autres convertibles. Un nouveau CUSIP 290257500 et l’ISIN CA2902575000 seront applicables. Les fractions d’actions seront arrondies à la baisse si <0,5 et à la hausse si ≥0,5. Les actionnaires inscrits sous forme certificée recevront une lettre de transmission de Computershare; les détenteurs DRS recevront automatiquement les relevés DRS post-consolidation. Les détenteurs non inscrits doivent consulter leurs intermédiaires. Les détenteurs de warrants seront notifiés selon les clauses applicables des warrants.
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY) hat eine 1-für-10-Aktienzusammenlegung mit Wirkung zum Handelseröffnungstag am 6. November 2025 genehmigt. Die Zusammenlegung wird die ausstehenden Stammaktien von 374.114.284 vor der Zusammenlegung auf ca. 37.411.430 nach der Zusammenlegung reduzieren, vorbehaltlich Rundung.
Proportionale Anpassungen gelten für ausstehende Aktienoptionen, Warrants und andere Wandelschuldinstrumente. Neuer CUSIP 290257500 und ISIN CA2902575000 werden angewendet. Bruchteilaktien werden abgerundet, wenn <0,5 und aufgerundet, wenn ≥0,5 ist. Registrierte Anteilseigner in zertifizierter Form erhalten ein Übertragungsschreiben von Computershare; DRS-Inhaber erhalten nach der Konsolidierung automatisch DRS-Abrechnungen. Nicht registrierte Inhaber sollten ihre Zwischenhändler konsultieren. Warranthalter werden gemäß den einschlägigen Warrantsbedingungen benachrichtigt.
ELSE NUTRITION (OTCQX:BABYF / TSX:BABY) وافقت على توحيد الأسهم بنسبة 1 مقابل 10 فعال عند افتتاح السوق في 6 نوفمبر 2025. ستقلل عملية التوحيد عدد الأسهم العادية Issued and outstanding من 374,114,284 قبل التوحيد إلى نحو 37,411,430 بعد التوحيد، مع الاعتماد على التقريب.
سيتم تطبيق تعديلات نسبية على خيارات الأسهم القائمة، والمشتقات، والوظائف القابلة للتحويل الأخرى. وسيتم تطبيق CUSIP جديد 290257500 ورمز ISIN CA2902575000. ستُقَرب الأسهم الكسرية إلى الأسفل إذا كان <0.5 وإلى الأعلى إذا كان ≥0.5. سيتلقى المساهمون المسجلون في الشكل الموثق رسالة تحويل من Computershare؛ سيحصل حاملو DRS تلقائياً على كشوفات DRS بعد التوحيد. يجب على الحاملين غير المسجلين استشارة وسطاءهم. سيتم إخطار حاملي الضمانات وفقاً لبنود الضمانات المعمول بها.
- Outstanding common shares reduced by ~90% to ~37.4M post-consolidation
- Post-consolidation trading to commence on Nov 6, 2025 on TSX under symbol BABY
- Proportionate adjustments made to stock options, warrants, and convertibles
- Fractional interests <0.5 will be rounded down, possibly reducing small holdings
- Registered shareholders must complete a letter of transmittal to exchange certificates, creating administrative steps
The common shares will continue to be listed on the TSX under the symbol "BABY" on a post-consolidation basis under the new CUSIP and new ISIN numbers, 290257500 and CA2902575000, respectively.
As a result of the share consolidation the number of issued and outstanding common shares of the Company will be reduced from 374,114,284 pre-consolidation common shares to approximately 37,411,430 post-consolidation common shares, subject to adjustments for rounding. Proportionate adjustments have been made to the Company's outstanding stock options, warrants, and other convertible securities. No fractional common shares will be issued as a result of the share consolidation. Any fractional interest in common shares that is less than 0.5 of a common share resulting from the share consolidation will be rounded down to the nearest whole common share, and any fractional interest in common shares that is equal to or greater than 0.5 of a common share will be rounded up to the nearest whole common share.
The Company's registered shareholders holding their common shares in certificated form will receive a letter of transmittal from Computershare Investor Services Inc., the Company's transfer agent, in respect to the share consolidation, which each registered shareholder will need to sign and complete. The letter of transmittal will contain instructions to registered shareholders on how to surrender the certificates representing their pre-consolidation common shares and authorize Computershare to issue a direct registration advice(s) (DRS) representing their post-consolidation common shares. The Company's registered shareholders whose common shares are represented by a DRS statement will not be required to complete and sign a letter of transmittal, and a DRS statement representing their post-consolidation common shares will automatically be issued to those registered shareholder by Computershare.
Non-registered shareholders who hold their common shares through an intermediary such as a bank, trust company, securities dealer or broker should note that these intermediaries may have their own procedures for processing the share consolidation which may differ from those described above for registered shareholders. Non-registered shareholders who have questions should contact their intermediary for more information.
Registered holders of the Company's warrants issued on October 20, 2021, will be given notice of the effect of the share consolidation pursuant to the Warrant Indenture dated October 20, 2021 between the Company and Computershare. Registered holders of the Company's warrants issued on June 29, 2022, will be given notice of the effect of the share consolidation pursuant to the Warrant Indenture dated June 29, 2022.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at
Milan's Global Food Innovation Summit - #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
- During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
Caution Regarding Forward-Looking Statements
This news release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this news release include but are not limited to, statements relating to current intent, belief, and expectations with respect to: the trading of the post-consolidation shares on the TSX and the expected timing thereof, the number of post-consolidation shares following the share consolidation, and the timing and process for issuing post-consolidation shares. These forward-looking statements are made as of the date of this news release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this news release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, variations in market conditions; currency exchange rates; the Company's ability to obtain any necessary permits, consents or authorizations required for its activities; the Company's ability to access further funding, to continue its projected growth, or to be fully able to implement its business strategies. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this news release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-announces-share-consolidation-302603127.html
SOURCE Else Nutrition Holdings Inc.